目的 毛叶假鹰爪素C(Des-C)衍生物的进一步优化设计合成,及其抗肿瘤作用机制的初步探讨。方法 结合已报道的毛叶假鹰爪素C衍生物,进行比较分子场法(CoMFA)分析,构建模型,指导设计新结构衍生物,对合成衍生物进行体外抗肿瘤细胞活性评价,验证模型有效性,运用流式细胞技术考察衍生物对细胞凋亡的影响。结果 构建的模型可有效指导衍生物的设计合成并预测毛叶假鹰爪素C衍生物的活性,通过优化合成路线,得到10个新衍生物,对A549和HL60的抗肿瘤活性明显提高,并且可通过诱导细胞凋亡来发挥抗肿瘤作用。结论 通过对先导物毛叶假鹰爪素C进行结构修饰和改造可有效提高化合物的抗肿瘤活性,初步明确了衍生物可通过诱导肿瘤细胞凋亡发挥抗肿瘤作用,为后续衍生物的研究提供方向和数据支持。
Abstract
OBJECTIVE To further design and synthesize Desmosdumotin-C(Des-C) derivatives and investigate their antitumor activities. METHODS QSAR study using the CoMFA method was performed on a set of reported Des-C derivatives to facilitate the elucidation of their SAR and discovery of new potent Des-C derivatives. Flow cytometry was used to investigate antitumor activity. RESULTS The established model showed good predictive ability and aid in the design of potent Des-C derivatives. An efficient three-step synthetic strategy toward Des-C derivatives was developed and applied to synthesize 10 new derivatives which showed superior antitumor activities against A549 and HL60 cells in vitro. CONCLUSION The structural modification of Des-C would significantly increase the antitumor activity. It is preliminarily confirmed that the derivatives are potent antitumor agents with apoptosis-inducing ability, which provides the basis for the further study.
关键词
毛叶假鹰爪素C衍生物 /
比较分子场法分析 /
构效关系研究 /
合成 /
抗肿瘤 /
凋亡
{{custom_keyword}} /
Key words
Des-C derivatives /
CoMFA study /
structure-activity relationship /
synthesis /
antitumor /
apoptosis
{{custom_keyword}} /
中图分类号:
R97
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] NEWMAN D J,CRAGG G M. Natural products as sources of new drugs over the 30 years from 1981 to 2010 [J]. J Nat Prod,2012,75(3):311-335.
[2] WU J H,LIAO S X,MAO S L,et al. Desmosflavanone Ⅱ. A new flavonone from Desmos cochinchinensis Lour [J]. J Chin Pharm Sci(中国药学英文版),1997,6(3): 7-9.
[3] WU J H,LIAO S X,LIANG H Q,et al . Studies on the structure and activity of anti-HIV compounds in Desmos dumosus [J]. Chin Pharm J(中国药学杂志),2005,40(7): 495-497.
[4] WU J H,MCPHAILB A T,BASTOWC K F. Desmosdumotin C, a novel cytotoxic principle from Desmos dumosus [J]. Tetra Lett,2002,43(8): 1391-1393.
[5] NAKAGAWA G K,CHEN T H,PENG C Y,et al. Antitumor Agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs [J]. J Med Chem,2007,50(14): 3354-3358.
[6] SONG M Y,WU J H,SHI N,et al. Synthesis of analogs of desmosdumotin C [J]. Chin J Nat Med(中国天然药物),2009,7(6):432-435.
[7] NAKAGAWA G K,WU P C,BASTOW K F,et al. Antitumor agents 283. Further elaboration of desmosdumotin C analogs as potent antitumor agents: activation of spindle assembly checkpoint as possible mode of action [J]. Bioorg Med Chem,2011,19(5):1816-1822.
[8] GUO H J,LIANG H,XIANG Z,et al. Protective effects of a chalcone derivative G01 on H2O2-induced oxidative damage in cortical neurons of mice [J]. Nat Prod Res Dev(天然产物研究与开发),2015,27(17):2138-2141.
[9] SIDAHMED H M A,AZIZAN A H S,MOHAN S,et al. Gastroprotective effect of desmosdumotin C isolated from mitrella kentii against ethanol-induced gastric mucosal hemorrhage in rats: possible involvement of glutathione, heat-shock protein-70, sulfhydryl compounds, nitric oxide, and anti-helicobacter pylori activity [J]. BMC Comp Alter Med,2013,13(1):1-15.
[10] XIANGZ Z. Design, synthesis and mechanism of in vitro anti-tumor, anti-oxidation action study of novel chalcones Des-C, FMC analogous [D]. Xi′an:Fourth Military Medical University, 2014.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金资助项目(81470156);山东省医药卫生科技发展计划项目资助(2016WS0734)
{{custom_fund}}